Botulinum toxin treatment for hypersalivation in anti-NMDA receptor encephalitis.

about

Botulinum toxin treatment for hypersalivation in anti-NMDA receptor encephalitis.

Item

http://www.wikidata.org/entity/Q47100635

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Botulinum toxin treatment for hypersalivation in anti-NMDA receptor encephalitis.

@en

Botulinum toxin treatment for hypersalivation in anti-NMDA receptor encephalitis.

@nl

type

Item

label

Botulinum toxin treatment for hypersalivation in anti-NMDA receptor encephalitis.

@en

Botulinum toxin treatment for hypersalivation in anti-NMDA receptor encephalitis.

@nl

prefLabel

Botulinum toxin treatment for hypersalivation in anti-NMDA receptor encephalitis.

@en

Botulinum toxin treatment for hypersalivation in anti-NMDA receptor encephalitis.

@nl

P1476

Botulinum toxin treatment for hypersalivation in anti-NMDA receptor encephalitis

@en

P2093

Han Gil Seo

http://www.w3.org/2001/XMLSchema#string

Kon Chu

http://www.w3.org/2001/XMLSchema#string

Sang Kun Lee

http://www.w3.org/2001/XMLSchema#string

Soon-Tae Lee

http://www.w3.org/2001/XMLSchema#string

P2860

Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis

Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study

Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies

Drooling.

N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes.

A systematic review for evidence of efficacy of anticholinergic drugs to treat drooling.

Botulinum toxin in the treatment of drooling in tetraplegic patients with brain injury.

The management of drooling in adults with neurological conditions.

Botulinum toxin for the treatment of sialorrhea: a meta-analysis.

Anti-LGI1 encephalitis is associated with unique HLA subtypes.

P304

830-834

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/ACN3.467

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Jin-Sun Jun

P577

2017-09-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29159196

http://www.w3.org/2001/XMLSchema#string

P932

5682120

http://www.w3.org/2001/XMLSchema#string